XML 31 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Gain (Loss) [Member]
Balances at Dec. 31, 2022 $ 110,903 $ 43 $ 262,496 $ (151,605) $ (31)
Beginning balance, shares at Dec. 31, 2022   43,269,200      
Exercise of stock options 33   33    
Exercise of stock options, shares   11,466      
Exercise of warrants 6   6    
Exercise of warrants, shares   628,403      
Stock-based compensation expense 7,615   7,615    
Unrealized gain on marketable debt securities 112       112
Net loss (36,949)     (36,949)  
Balances at Dec. 31, 2023 81,720 $ 43 270,150 (188,554) 81
Ending balance, shares at Dec. 31, 2023   43,909,069      
Issuance of common stock, net 161,756 $ 20 161,736    
Issuance of common stock, net, shares   19,736,842      
Vesting of restricted stock units   $ 1 (1)    
Vesting of restricted stock units, shares   153,750      
Exercise of stock options $ 77   77    
Exercise of stock options, shares 15,404 15,404      
Stock-based compensation expense $ 8,796   8,796    
Unrealized gain on marketable debt securities 67       67
Net loss (80,604)     (80,604)  
Balances at Dec. 31, 2024 $ 171,812 $ 64 $ 440,758 $ (269,158) $ 148
Ending balance, shares at Dec. 31, 2024   63,815,065